icon-folder.gif   Conference Reports for NATAP  
 
  63rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 9-12 2012		 Back grey_arrow_rt.gif
 
 
 
A Combination Containing MK-5172 (HCV NS3 protease inhibitor) and MK-8742 (HCV NS5A inhibitor) Demonstrates High Barrier to Resistance in HCV Replicon
 
 
  Reported by Jules Levin
AASLD Nov 9-13 2012 Boston
 
Frederick Lahser, Rong Liu, Karin Bystol,
Ellen Xia, Richard Raubertas,
Ernest Asante-Appiah, Anita Y. M. Howe

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif